Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease

Documenti analoghi

• Nationwide Trends in Liver Stiffness Measurement in Japan: A Real‐World Evidence of NILDA Using the National Database of Health Insurance Claims
  di: Masahito Nakano, et al.
  Pubblicazione: (2025)
• Association of liver fibrosis progression with non–liver‐related mortality in metabolic dysfunction‐associated steatotic liver disease
  di: Toshifumi Tada, et al.
  Pubblicazione: (2025)
• Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease
  di: Kazuhiro Nouso, et al.
  Pubblicazione: (2024)
• Aspartate aminotransferase‐to‐platelet ratio index outperforms Fibrosis‐4 in 2843 Korean patients with metabolic dysfunction‐associated steatotic liver disease
  di: Se Young Jang, et al.
  Pubblicazione: (2024)
• Metabolic dysfunction‐associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study
  di: Tomonori Cho, et al.
  Pubblicazione: (2025)